Bristol-Myers Squibb Company (BMY)
BMV
1,088.50
+18.50 (+1.73%)
Closed
Oct 9, 2026
Day's Range
1,088.501,088.50
52 wk Range
789.001,153.00
Financial Statements - BMY - Bristol-Myers Squibb Company
Revenue
48.19B▼ 94.2%
Net Income
7.05B▲ 104.6%Net Margin 14.6%
EBITDA
19.94B▼ 93.3%
Free Cash Flow
12.84B▼ 94.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 48.19B | 833.62B | 45B | 46.15B | 46.38B | 42.51B |
| Cost of Goods | 13.93B | 241.07B | 10.69B | 10.13B | 9.94B | 11.77B |
| Gross Profit | 34.25B | 592.54B | 34.31B | 36.02B | 36.44B | 30.74B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 13.72B | 101.60B | 8.19B | 9.10B | 8.53B | 2.17B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -2.50B | -212.61B | 1.41B | -159M | 895M | -7.62B |
| Pre Tax Income | 9.32B | -144.61B | 8.44B | 7.71B | 8.09B | -6.87B |
| Income Tax | 2.27B | 9.56B | 400M | 1.36B | 1.08B | 2.12B |
| Net Income | 7.05B | -154.17B | 8.04B | 6.34B | 7.01B | -8.99B |
| EPS Basic | 3.47 | -4.41 | 3.88 | 2.97 | 3.24849 | -3.99 |
| EPS Diluted | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 | -3.99 |
| Basic Shares Outstanding | 2.03B | 34.98B | 101.31M | 104.30M | 105.42M | 110.57M |
| Diluted Shares Outstanding | 2.03B | 34.98B | 101.31M | 104.30M | 105.42M | 110.57M |
| Ebit | 11.21B | -111.01B | 9.60B | 8.94B | 9.43B | -5.45B |
| Ebitda | 19.94B | 296.20B | 19.40B | 20.58B | 20.37B | 14.28B |
| Net Income Continuous Operations | 7.05B | -154.17B | 8.04B | 6.34B | 7.01B | -8.99B |
| Minority Interests | -2M | -15M | -15M | -18M | -20M | -20M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
